Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KMB vs MRNA✓SelectedUSD · MRNAKMB vs MRNA performance historyLatest closeAs of+1.07%11/20
Stock and ETF performance explorer

KMB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-0.1%
MRNA return
+153.9%
Excess return
-154.0%
Maximum drawdown
-34.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.1%-2.2%+3.2%+1.1%
7D-2.8%-12.7%+9.9%-2.6%
30D-0.2%-20.7%+20.4%0.0%
3M-1.0%+46.3%-47.2%-1.7%
6M+11.9%+305.2%-293.4%+8.0%
YTD+9.5%+561.2%-551.7%+3.9%
1Y+7.8%+772.1%-764.3%+1.2%
3Y-0.1%+147.0%-147.1%-4.0%
All-0.1%+153.9%-154.0%-4.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling